| SKU | ISG005013 |
| Brand | Movigit |
| Categories | Medication & Treatments |
| Color | black |
| Concentrations | 50 Mg |
| Shop by Concerns | Delayed Gastric Emptying |
| Gender | Neutral |
| Shop By Goals | Improve Hair Shine |
| Ingredient | Itopride |
| UPC | 6221508512916 |
| Product Form | Tablets |
| Specialty | Clinically Tested Gastrointestinal Support Prescription Use |
| Sub Categories | Motility Stimulant |
| Unit Count | 30 Tablets |
| Warning | Keep Out Of Reach Of Children Avoid use in pregnancy unless directed by a doctor Caution in liver and kidney impairment Contraindicated in gastrointestinal obstruction Use under medical supervision only |
Movigit 50 Mg 30 Tablets
Description:
Movigit 50 mg 30 tablets is a prescription oral medicine containing itopride, a gastrointestinal motility stimulant (prokinetic agent). It is used to improve gastric emptying and relieve symptoms associated with functional dyspepsia and delayed gastric emptying, such as bloating, early satiety, upper abdominal discomfort, and nausea. Movigit works by enhancing gastrointestinal peristalsis through dopamine D2 receptor antagonism and increasing acetylcholine activity in the gut, helping restore normal stomach and intestinal motility. This product is intended for adult use under medical supervision.
Indications:
- Functional dyspepsia (indigestion) associated with delayed gastric emptying.
- Symptoms of upper gastrointestinal motility disorders, such as bloating, fullness, early satiety, and epigastric discomfort.
- Adjunct treatment for nausea and vomiting related to impaired gastric motility (as assessed by a physician).
- Supportive management of gastroesophageal reflux symptoms where impaired gastric emptying contributes to complaints (as directed by a doctor).
Active Ingredients / Key Components:
- Itopride hydrochloride – 50 mg per film-coated tablet.
- Other excipients (tablet core and coating) – exact composition and concentrations , please check the product leaflet or the manufacturer’s official website; please refer to the official package leaflet for full excipient list.
Dosage & Administration / How to Use:
- Adults (oral): The typical recommended dose is 50 mg (1 tablet) three times daily.
- Tablets should be taken before meals, usually about 30 minutes prior to breakfast, lunch, and dinner, or as directed by your physician.
- Swallow the tablet whole with a sufficient amount of water; do not crush or chew the film-coated tablet unless your doctor or pharmacist advises otherwise.
- Duration of treatment depends on the severity of symptoms and your doctor’s assessment; do not use for longer than prescribed.
- If you miss a dose, take it as soon as you remember unless it is almost time for the next dose. Do not double the dose to make up for a missed dose.
- Use in children and adolescents: safety and dosage have not been well established; use only if specifically prescribed by a pediatric specialist.
- Always follow your doctor’s instructions and the directions on the product label. Do not adjust the dose or stop treatment without medical advice.
Clinical Benefits:
- Enhances gastric motility and accelerates gastric emptying, helping to normalize stomach function.
- Relieves symptoms of functional dyspepsia such as bloating, fullness, and upper abdominal discomfort.
- Improves esophageal and gastrointestinal peristalsis and lower esophageal sphincter pressure, which may help reduce reflux-related complaints.
- Provides anti-emetic effect through dopamine D2 receptor antagonism at the chemoreceptor trigger zone (CTZ), helping reduce nausea and vomiting associated with motility disorders.
Warnings & Contraindications:
- Contraindicated in patients with known hypersensitivity or allergy to itopride or any of the excipients in the formulation.
- Do not use in patients with gastrointestinal bleeding, mechanical obstruction, perforation, or severe gastrointestinal disease where increased motility may be harmful.
- Use with caution in patients with severe renal or hepatic impairment; dose adjustment or close monitoring may be required as determined by a physician.
- Itopride may interact with other prokinetic agents (such as cisapride) and anticholinergic drugs (such as atropine), which can alter its effect; inform your doctor about all medications you are taking.
- Consult your doctor before use if pregnant or planning pregnancy. Use during pregnancy should be based on a clear medical need and under strict medical supervision.
- Consult your doctor before use if you are breastfeeding; it is not known with certainty whether itopride is excreted in human milk. A risk–benefit assessment is required.
- Consult your doctor before use if you have liver disease, kidney disease, history of gastrointestinal surgery, or any chronic medical condition.
- Although itopride is not primarily sedating, if you experience dizziness or drowsiness, avoid driving or operating machinery until you know how the medicine affects you.
- Not intended to diagnose, treat, cure, or prevent any disease without proper medical evaluation and prescription.
- Keep out of reach of children.
Side Effects:
- Common side effects may include abdominal discomfort, diarrhea, constipation, nausea, or increased salivation.
- Less common side effects can include headache, dizziness, fatigue, or changes in liver enzymes (as detected by blood tests).
- Allergic reactions such as skin rash, itching, or swelling may occur in sensitive individuals. Stop the medication and seek medical advice if these appear.
- Serious but rare side effects may include severe abdominal pain, persistent vomiting, jaundice (yellowing of skin or eyes), or signs of severe allergic reaction (difficulty breathing, facial or throat swelling). Seek immediate medical attention if any of these occur.
- If you experience any unexpected or bothersome side effects, contact your doctor or pharmacist promptly.
Storage Instructions:
Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children. Do not use after the expiry date printed on the package. Store at or below the temperature specified on the outer carton or blister (refer to the official pack; exact storage temperature is not available in the provided information).
Specifications:
- Active ingredient: itopride hydrochloride 50 mg per film-coated tablet.
- Form: film-coated oral tablets.
- Pack size: 30 tablets per pack.
- Intended use: prescription gastrointestinal motility stimulant for adults, as directed by a healthcare professional.
Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.
